Sodium Phosphates (Hospira, Inc.)
Welcome to the PulseAid listing for the Sodium Phosphates drug offered from Hospira, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE and SODIUM PHOSPHATE, DIBASIC, ANHYDROUS |
SUBSTANCE NAME: | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2005-06-02 |
END MARKETING DATE: | 0000-00-00 |
Sodium Phosphates HUMAN PRESCRIPTION DRUG Details:
Item Description | Sodium Phosphates from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 276; 142(mg/mL; mg/mL) |
START MARKETING DATE: | 2005-06-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-7391_c8cbcd2d-9d3a-470e-8201-00c24e7b85c7 |
PRODUCT NDC: | 0409-7391 |
APPLICATION NUMBER: | NDA018892 |
Other SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS Pharmaceutical Manufacturers / Labelers: